arXiv subjects

Yasushi Okuno

Publications and source records attributed to Yasushi Okuno.

14 recordsLinked to original sources

arXiv2026

A Quantum-HPC Hybrid Workflow for Reaction-Center Electronic Dynamics: Application to a Cytochrome P450-Inspired Iron-Complex Model

We introduce population-transfer dynamics as a practical validation observable for active-space-derived reduced Hamiltonians in multistate reaction-center chemistry. Using a cytochrome P450-inspired Fe-complex model, we construct a reaction-coordinate-dependent effective Hamiltonian from state-averaged complete active-space self-consistent field (SA-CASSCF) calculations, map it to a quantum-circuit representation suitable for current hardware, and propagate dynamics from the reactant-side ground state. The reduced Hamiltonian reproduces the SA-CASSCF reference with an RMS deviation of 0.030 eV and a maximum absolute deviation of 0.143 eV. As a dynamics-based diagnostic, the product-manifold population p_P(t) identifies a pronounced near-degeneracy region around x = 0.3, where state mixing is strongest. Classical exact time evolution yields a product population of 0.488 at x = 0.3 after 10 fs, compared with 7.26 x 10^-2 at x = 0.2 and 5.90 x 10^-3 at x = 0.0. To enable execution on current trapped-ion hardware, we examine the trade-off between dynamical fidelity and circuit resources through coupling pruning and first-order Trotterization. A coupling cutoff of 0.02 eV reduces the non-zero coupling set from 32 to 7 while preserving the dominant transfer pathways, and M = 30 provides the best practical operating point. Finally, we demonstrate the workflow on Quantinuum's trapped-ion quantum computer Reimei. The hardware reproduces the key reaction-coordinate trend identified by the classical model, including the maximum at x = 0.3, where the measured product population is 0.42 on hardware and 0.43 on the matched emulator. This work establishes a dynamics-based framework for assessing active-space-derived reduced Hamiltonians and demonstrates chemically interpretable multistate electronic dynamics on current trapped-ion hardware.

quant-ph↗

arXiv2026

A Nationwide Japanese Medical Claims Foundation Model: Balancing Model Scaling and Task-Specific Computational Efficiency

Clinical risk prediction using longitudinal medical data supports individualized care. Self-supervised foundation models have emerged as a promising approach for leveraging large-scale unlabeled healthcare records. In natural language processing, scaling laws suggest that larger models achieve predictably lower pretraining losses, supporting the foundation model paradigm. However, for structured medical data, characterized by a limited vocabulary and sparse observations, whether increasing model size consistently improves downstream predictions is unclear, as most studies evaluate only a single model scale. In this study, we evaluated the relationship between model scale and downstream task performance for structured medical foundation models. Using a random sample (2.3 million patients, 32 hospitals) from a nationwide 519-hospital Japanese claims database, we pretrained encoder-only Transformers at five scales (2.2M-101M parameters) for disease incidence and medication prediction. Downstream performance saturated at task-dependent thresholds: disease prediction benefited from larger models (32M-101M), whereas medication prediction saturated at 11M, reducing pretraining time by 178 h. Across all tasks, the best-performing model consistently outperformed a Light Gradient Boosting Machine baseline in the area under the precision-recall curve. These findings indicate that, unlike the monotonically decreasing pretraining loss, the optimal model size varied depending on task characteristics. This task-dependent saturation provides practical guidance for balancing predictive performance and computational cost in structured medical foundation models.

cs.LG↗

arXiv2026

ClinDet-Bench: Beyond Abstention, Evaluating Judgment Determinability of LLMs in Clinical Decision-Making

Clinical decisions are often required under incomplete information. Clinical experts must identify whether available information is sufficient for judgment, as both premature conclusion and unnecessary abstention can compromise patient safety. To evaluate this capability of large language models (LLMs), we developed ClinDet-Bench, a benchmark based on clinical scoring systems that decomposes incomplete-information scenarios into determinable and undeterminable conditions. Identifying determinability requires considering all hypotheses about missing information, including unlikely ones, and verifying whether the conclusion holds across them. We find that recent LLMs fail to identify determinability under incomplete information, producing both premature judgments and excessive abstention, despite correctly explaining the underlying scoring knowledge and performing well under complete information. These findings suggest that existing benchmarks are insufficient to evaluate the safety of LLMs in clinical settings. ClinDet-Bench provides a framework for evaluating determinability recognition, leading to appropriate abstention, with potential applicability to medicine and other high-stakes domains, and is publicly available.

cs.AI↗

arXiv2025

HELM-BERT: A Transformer for Medium-sized Peptide Property Prediction

Therapeutic peptides have emerged as a pivotal modality in modern drug discovery, occupying a chemically and topologically rich space. While accurate prediction of their physicochemical properties is essential for accelerating peptide development, existing molecular language models rely on representations that fail to capture this complexity. Atom-level SMILES notation generates long token sequences and obscures cyclic topology, whereas amino-acid-level representations cannot encode the diverse chemical modifications central to modern peptide design. To bridge this representational gap, the Hierarchical Editing Language for Macromolecules (HELM) offers a unified framework enabling precise description of both monomer composition and connectivity, making it a promising foundation for peptide language modeling. Here, we propose HELM-BERT, the first encoder-based peptide language model trained on HELM notation. Based on DeBERTa, HELM-BERT is specifically designed to capture hierarchical dependencies within HELM sequences. The model is pre-trained on a curated corpus of 39,079 chemically diverse peptides spanning linear and cyclic structures. HELM-BERT significantly outperforms state-of-the-art SMILES-based language models in downstream tasks, including cyclic peptide membrane permeability prediction and peptide-protein interaction prediction. These results demonstrate that HELM's explicit monomer- and topology-aware representations offer substantial data-efficiency advantages for modeling therapeutic peptides, bridging a long-standing gap between small-molecule and protein language models.

cs.LG↗

arXiv2025

Out-of-distribution Reject Option Method for Dataset Shift Problem in Early Disease Onset Prediction

Machine learning is increasingly used to predict lifestyle-related disease onset using health and medical data. However, its predictive accuracy for use is often hindered by dataset shift, which refers to discrepancies in data distribution between the training and testing datasets. This issue leads to the misclassification of out-of-distribution (OOD) data. To diminish dataset shift in real-world settings, this paper proposes the out-of-distribution reject option for prediction (ODROP). This method integrates an OOD detection model to preclude OOD data from the prediction phase. We used two real-world health checkup datasets (Hirosaki and Wakayama) with dataset shift, across three disease onset prediction tasks: diabetes, dyslipidemia, and hypertension. Both components of ODROP method -- the OOD detection model and the prediction model -- were trained on the Hirosaki dataset. We assessed the effectiveness of ODROP on the Wakayama dataset using AUROC-rejection rate curve plot. In the five OOD detection approaches (the variational autoencoder, neural network ensemble std, neural network ensemble epistemic, neural network energy, and neural network gaussian mixture based energy measurement), the variational autoencoder method demonstrated notably higher stability and a greater improvement in AUROC. For example, in the Wakayama dataset, the AUROC for diabetes onset increased from 0.80 without ODROP to 0.90 at a 31.1% rejection rate, and for dyslipidemia, it improved from 0.70 without ODROP to 0.76 at a 34% rejection rate. In addition, we categorized dataset shifts into two types using SHAP clustering -- those that considerably affect predictions and those that do not. This study is the first to apply OOD detection to actual health and medical data, demonstrating its potential to substantially improve the accuracy and reliability of disease prediction models amidst dataset shift.

cs.LG↗

arXiv2023

A New Deep State-Space Analysis Framework for Patient Latent State Estimation and Classification from EHR Time Series Data

Many diseases, including cancer and chronic conditions, require extended treatment periods and long-term strategies. Machine learning and AI research focusing on electronic health records (EHRs) have emerged to address this need. Effective treatment strategies involve more than capturing sequential changes in patient test values. It requires an explainable and clinically interpretable model by capturing the patient's internal state over time. In this study, we propose the "deep state-space analysis framework," using time-series unsupervised learning of EHRs with a deep state-space model. This framework enables learning, visualizing, and clustering of temporal changes in patient latent states related to disease progression. We evaluated our framework using time-series laboratory data from 12,695 cancer patients. By estimating latent states, we successfully discover latent states related to prognosis. By visualization and cluster analysis, the temporal transition of patient status and test items during state transitions characteristic of each anticancer drug were identified. Our framework surpasses existing methods in capturing interpretable latent space. It can be expected to enhance our comprehension of disease progression from EHRs, aiding treatment adjustments and prognostic determinations.

cs.LG↗

arXiv2023

An end-to-end framework for gene expression classification by integrating a background knowledge graph: application to cancer prognosis prediction

Biological data may be separated into primary data, such as gene expression, and secondary data, such as pathways and protein-protein interactions. Methods using secondary data to enhance the analysis of primary data are promising, because secondary data have background information that is not included in primary data. In this study, we proposed an end-to-end framework to integrally handle secondary data to construct a classification model for primary data. We applied this framework to cancer prognosis prediction using gene expression data and a biological network. Cross-validation results indicated that our model achieved higher accuracy compared with a deep neural network model without background biological network information. Experiments conducted in patient groups by cancer type showed improvement in ROC-area under the curve for many groups. Visualizations of high accuracy cancer types identified contributing genes and pathways by enrichment analysis. Known biomarkers and novel biomarker candidates were identified through these experiments.

q-bio.QM↗

arXiv2022

GraphIX: Graph-based In silico XAI(explainable artificial intelligence) for drug repositioning from biopharmaceutical network

Drug repositioning holds great promise because it can reduce the time and cost of new drug development. While drug repositioning can omit various R&D processes, confirming pharmacological effects on biomolecules is essential for application to new diseases. Biomedical explainability in a drug repositioning model can support appropriate insights in subsequent in-depth studies. However, the validity of the XAI methodology is still under debate, and the effectiveness of XAI in drug repositioning prediction applications remains unclear. In this study, we propose GraphIX, an explainable drug repositioning framework using biological networks, and quantitatively evaluate its explainability. GraphIX first learns the network weights and node features using a graph neural network from known drug indication and knowledge graph that consists of three types of nodes (but not given node type information): disease, drug, and protein. Analysis of the post-learning features showed that node types that were not known to the model beforehand are distinguished through the learning process based on the graph structure. From the learned weights and features, GraphIX then predicts the disease-drug association and calculates the contribution values of the nodes located in the neighborhood of the predicted disease and drug. We hypothesized that the neighboring protein node to which the model gave a high contribution is important in understanding the actual pharmacological effects. Quantitative evaluation of the validity of protein nodes' contribution using a real-world database showed that the high contribution proteins shown by GraphIX are reasonable as a mechanism of drug action. GraphIX is a framework for evidence-based drug discovery that can present to users new disease-drug associations and identify the protein important for understanding its pharmacological effects from a large and complex knowledge base.

cs.LG↗

arXiv2022

Individual health-disease phase diagrams for disease prevention based on machine learning

Early disease detection and prevention methods based on effective interventions are gaining attention. Machine learning technology has enabled precise disease prediction by capturing individual differences in multivariate data. Progress in precision medicine has revealed that substantial heterogeneity exists in health data at the individual level and that complex health factors are involved in the development of chronic diseases. However, it remains a challenge to identify individual physiological state changes in cross-disease onset processes because of the complex relationships among multiple biomarkers. Here, we present the health-disease phase diagram (HDPD), which represents a personal health state by visualizing the boundary values of multiple biomarkers that fluctuate early in the disease progression process. In HDPDs, future onset predictions are represented by perturbing multiple biomarker values while accounting for dependencies among variables. We constructed HDPDs for 11 non-communicable diseases (NCDs) from a longitudinal health checkup cohort of 3,238 individuals, comprising 3,215 measurement items and genetic data. Improvement of biomarker values to the non-onset region in HDPD significantly prevented future disease onset in 7 out of 11 NCDs. Our results demonstrate that HDPDs can represent individual physiological states in the onset process and be used as intervention goals for disease prevention.

cs.LG↗

arXiv2021

Complex network prediction using deep learning

Systematic relations between multiple objects that occur in various fields can be represented as networks. Real-world networks typically exhibit complex topologies whose structural properties are key factors in characterizing and further exploring the networks themselves. Uncertainty, modelling procedures and measurement difficulties raise often insurmountable challenges in fully characterizing most of the known real-world networks; hence, the necessity to predict their unknown elements from the limited data currently available in order to estimate possible future relations and/or to unveil unmeasurable relations. In this work, we propose a deep learning approach to this problem based on Graph Convolutional Networks for predicting networks while preserving their original structural properties. The study reveals that this method can preserve scale-free and small-world properties of complex networks when predicting their unknown parts, a feature lacked by the up-to-date conventional methods. An external validation realized by testing the approach on biological networks confirms the results, initially obtained on artificial data. Moreover, this process provides new insights into the retainability of network structure properties in network prediction. We anticipate that our work could inspire similar approaches in other research fields as well, where unknown mechanisms behind complex systems need to be revealed by combining machine-based and experiment-based methods.

physics.soc-ph↗

arXiv2020

Health improvement framework for planning actionable treatment process using surrogate Bayesian model

Clinical decision making regarding treatments based on personal characteristics leads to effective health improvements. Machine learning (ML) has been the primary concern of diagnosis support according to comprehensive patient information. However, the remaining prominent issue is the development of objective treatment processes in clinical situations. This study proposes a novel framework to plan treatment processes in a data-driven manner. A key point of the framework is the evaluation of the "actionability" for personal health improvements by using a surrogate Bayesian model in addition to a high-performance nonlinear ML model. We first evaluated the framework from the viewpoint of its methodology using a synthetic dataset. Subsequently, the framework was applied to an actual health checkup dataset comprising data from 3,132 participants, to improve systolic blood pressure values at the individual level. We confirmed that the computed treatment processes are actionable and consistent with clinical knowledge for lowering blood pressure. These results demonstrate that our framework could contribute toward decision making in the medical field, providing clinicians with deeper insights.

cs.LG↗

arXiv2020

Dynamic change of gene-to-gene regulatory networks in response to SARS-CoV-2 infection

The current pandemic of SARS-CoV-2 has caused extensive damage to society. The characterization of SARS-CoV-2 profiles has been addressed by researchers globally with the aim of resolving this disruptive crisis. This investigation process is indispensable for an understanding of how SARS-CoV-2 behaves in human host cells. However, little is known about the systematic molecular mechanisms involved in the effect of SARS-CoV-2 infection on human host cells. Here, we have presented gene-to-gene regulatory networks in response to SARS-CoV-2 using a Bayesian network. We examined the dynamic changes of the SARS-CoV-2-purturbated networks established by our proposed framework for gene network analysis, revealing that interferon signaling gradually switches to the subsequent inflammatory-cytokine signaling cascades. Furthermore, we have succeeded in capturing a COVID-19 patient-specific network in which transduction of these signalings is coincidently induced. This enabled us to explore local regulatory systems influenced by SARS-CoV-2 in host cells more precisely at an individual level. Our panel of network analyses has provided new insight into SARS-CoV-2 research from the perspective of cellular systems.

q-bio.MN↗

arXiv2018

Efficient Construction Method for Phase Diagrams Using Uncertainty Sampling

We develop a method to efficiently construct phase diagrams using machine learning. Uncertainty sampling (US) in active learning is utilized to intensively sample around phase boundaries. Here, we demonstrate constructions of three known experimental phase diagrams by the US approach. Compared with random sampling, the US approach decreases the number of sampling points to about 20%. In particular, the reduction rate is pronounced in more complicated phase diagrams. Furthermore, we show that using the US approach, undetected new phase can be rapidly found, and smaller number of initial sampling points are sufficient. Thus, we conclude that the US approach is useful to construct complicated phase diagrams from scratch and will be an essential tool in materials science.

cond-mat.mtrl-sci↗

arXiv2012

On the behavior of tile assembly system at high temperatures

Behaviors of Winfree's tile assembly systems (TASs) at high temperatures are investigated in combination with integer programming of a specific form called threshold programming. First, we propose a way to build bridges from the Boolean satisfiability problem (SAT) to threshold programming, and further to TAS's behavior, in order to prove the NP-hardness of optimizing temperatures of TASs that behave in a way given as input. These bridges will take us further to two important results on the behavior of TASs at high temperatures. The first says that arbitrarily high temperatures are required to assemble some shape by a TAS of "reasonable" size. The second is that for any temperature at least 4 given as a parameter, it is NP-hard to find the minimum size TAS that self-assembles a given shape and works at the given temperature or below.

cs.CC↗